NCT05518136

Brief Summary

In this single-center, randomized controlled trial, patients (4-8 months) with CHD were randomly assigned to either a recovery group (home-based rehab exercise periodically) supervised by cellphone APP or to a control group. Left ventricular ejection fractions (LVEF), the rate of increase in heart rate (rHRI), and the rate of recovery heart rate (rHRR) were measured for representing cardiopulmonary capacity. The Alberta test and Neuro-intelligence Scale were used to evaluate their motor developmental outcomes. This study verified the feasibility of this rehab method and indicated that 6-month home-based exercise training can improve cardiopulmonary endurance and motor developmental level in infant CHD patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 10, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 28, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 18, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 26, 2022

Completed
Last Updated

August 26, 2022

Status Verified

August 1, 2022

Enrollment Period

9 months

First QC Date

August 18, 2022

Last Update Submit

August 24, 2022

Conditions

Keywords

infantrehab management APPhome-based exercisecardiopulmonary endurancemotor developmental level

Outcome Measures

Primary Outcomes (20)

  • Baseline LVEF

    Left ventricular ejection fraction before surgery

    pre-operative for baseline assessment

  • Baseline rHRI

    The rate of increase in heart rate before surgery

    pre-operative for baseline assessment

  • Baseline rHRR

    The rate of recovery heart rate before surgery

    pre-operative for baseline assessment

  • Baseline Alberta score

    Alberta motor test results before surgery

    pre-operative for baseline assessment

  • Baseline Neuro-intelligence Scale

    Developmental Quotient (DQ) before surgery

    pre-operative for baseline assessment

  • LVEF one month after the surgery

    Left ventricular ejection fraction one month after the surgery

    one month after surgery

  • rHRI one month after the surgery rHRI one month after the surgery

    The rate of increase in heart rate one month after the surgery

    one month after surgery

  • rHRR one month after the surgery

    The rate of recovery heart rate one month after the surgery

    one month after surgery

  • Alberta score one month after the surgery

    Alberta motor test results one month after the surgery

    one month after surgery

  • Neuro-intelligence Scale one month after the surgery

    Developmental Quotient (DQ) one month after the surgery

    one month after surgery

  • LVEF three months after the surgery

    Left ventricular ejection fraction three months after the surgery

    three months after surgery

  • rHRI three months after the surgery

    The rate of increase in heart rate three months after the surgery

    three months after surgery

  • rHRR three months after the surgery

    The rate of recovery heart rate three months after the surgery

    three months after surgery

  • Alberta score three months after the surgery

    Alberta motor test results three months after the surgery

    three months after surgery

  • Neuro-intelligence Scale three months after the surgery

    Developmental Quotient (DQ) three months after the surgery

    three months after surgery

  • LVEF six months after the surgery

    Left ventricular ejection fraction six months after the surgery

    six months after surgery

  • rHRI six months after the surgery

    The rate of increase in heart rate six months after the surgery

    six months after surgery

  • rHRR six months after the surgery

    The rate of recovery heart rate six months after the surgery

    six months after surgery

  • Alberta score six months after the surgery

    Alberta motor test results six months after the surgery

    six months after surgery

  • Neuro-intelligence Scale six months after the surgery

    Developmental Quotient (DQ) six months after the surgery

    six months after surgery

Study Arms (2)

Recovery group

EXPERIMENTAL

Recovery group was given home-based rehab exercise periodically supervised by cellphone APP. Left ventricular ejection fractions (LVEF), the rate of increase in heart rate (rHRI), and the rate of recovery heart rate (rHRR) were measured for representing cardiopulmonary capacity. The Alberta test and Neuro-intelligence Scale were used to evaluate their motor developmental outcomes.

Behavioral: exercise-guidance on rehab APP

Control group

NO INTERVENTION

General post-operative care for control group. Left ventricular ejection fractions (LVEF), the rate of increase in heart rate (rHRI), and the rate of recovery heart rate (rHRR) were measured for representing cardiopulmonary capacity. The Alberta test and Neuro-intelligence Scale were used to evaluate their motor developmental outcomes.

Interventions

Training motions included sitting balance, hand support, crawling and squatting training12-14 were scheduled for 1 to 3 months postoperatively, moreover, climbing over obstacles was for 3 to 6 months.

Recovery group

Eligibility Criteria

Age4 Months - 8 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • CHD infants (aged 4-8 months) with atrial septum defect (ASD) or ventricular septum defect (VSD)

You may not qualify if:

  • chromosomal abnormalities; family history of mental retardation; small for gestational age and prematurity; history of perinatal asphyxia and hyperbilirubinemia; history of central nervous system disease or imaging suggestive of brain dysplasia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Children's Hospital

Beijing, Beijing Municipality, 100000, China

Location

Related Publications (1)

  • Gurvitz M, Valente AM, Broberg C, Cook S, Stout K, Kay J, Ting J, Kuehl K, Earing M, Webb G, Houser L, Opotowsky A, Harmon A, Graham D, Khairy P, Gianola A, Verstappen A, Landzberg M; Alliance for Adult Research in Congenital Cardiology (AARCC) and Adult Congenital Heart Association. Prevalence and predictors of gaps in care among adult congenital heart disease patients: HEART-ACHD (The Health, Education, and Access Research Trial). J Am Coll Cardiol. 2013 May 28;61(21):2180-4. doi: 10.1016/j.jacc.2013.02.048. Epub 2013 Mar 28.

    PMID: 23542112BACKGROUND

MeSH Terms

Conditions

NeuritisPsychomotor Disorders

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Gejingwa Zhao

    Beijing Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Doctor, Doctor of Cardiac Surgery Department, Principal Investigator

Study Record Dates

First Submitted

August 18, 2022

First Posted

August 26, 2022

Study Start

April 10, 2021

Primary Completion

December 28, 2021

Study Completion

May 25, 2022

Last Updated

August 26, 2022

Record last verified: 2022-08

Locations